Cargando…
Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
Parkinson disease (PD) is the second most common neurodegenerative disorder and the leading neurodegenerative cause of motor disability. Pathologic accumulation of aggregated alpha synuclein (AS) protein in brain, and imbalance in the nigrostriatal system due to the loss of dopaminergic neurons in t...
Autores principales: | Jan, Asad, Jansonius, Brandon, Delaidelli, Alberto, Bhanshali, Forum, An, Yi Andy, Ferreira, Nelson, Smits, Lisa M., Negri, Gian Luca, Schwamborn, Jens C., Jensen, Poul H., Mackenzie, Ian R., Taubert, Stefan, Sorensen, Poul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027557/ https://www.ncbi.nlm.nih.gov/pubmed/29961428 http://dx.doi.org/10.1186/s40478-018-0554-9 |
Ejemplares similares
-
α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
por: Delaidelli, Alberto, et al.
Publicado: (2021) -
MEDB-18. Elongation control of mRNA translation supports Group 3 medulloblastoma adaptation to nutrient deprivation
por: Delaidelli, Alberto, et al.
Publicado: (2022) -
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
por: Jan, Asad, et al.
Publicado: (2021) -
EMBR-20. ELONGATION CONTROL OF MRNA TRANSLATION DRIVES GROUP 3 MEDULLOBLASTOMA
por: Delaidelli, Alberto, et al.
Publicado: (2021) -
Sarkosyl differentially solubilizes patient-derived alpha-synuclein fibril strains
por: Gram, Hjalte, et al.
Publicado: (2023)